Clinical Trials
3 trialsNCT07321847 2026-01-07
INJECTABL-3
Immunophotonics, Inc.
Phase 2/3 Not yet recruiting
NCT01384877 2019-07-12
Subcutaneous Lidocaine For Cancer-Related Pain
British Columbia Cancer Agency
Phase 2/3 Completed
NCT01379183 2016-03-21
Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Mayo Clinic
Phase 2/3 Completed